Shang Mengxuan, Zhou Fen, & Jin Runming. (2022). Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era. Frontiers Media S.A..
Chicago Style (17th ed.) CitationShang Mengxuan, Zhou Fen, and Jin Runming. Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationShang Mengxuan, et al. Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.